BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
<i>Clostridium butyricum</i> CGMCC0313.1 Protects against Autoimmune Diabetes by Modulating Intestinal Immune Homeostasis and Inducing Pancreatic Regulatory T Cells. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 8 Issue Pages: 1345 Pub: 2017 Epub: 2017 Oct 19 Authors Jia L , Shan K , Pan LL , Feng N , Lv Z , Sun Y , Li J , Wu C , Zhang H , Chen W , Diana J , Sun J , Chen YQ , |
|
|
<i>Clostridium butyricum</i> CGMCC0313.1 Protects against Autoimmune Diabetes by Modulating Intestinal Immune Homeostasis and Inducing Pancreatic Regulatory T Cells. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 8 Issue Pages: 1345 Pub: 2017 Epub: 2017 Oct 19 Authors Jia L , Shan K , Pan LL , Feng N , Lv Z , Sun Y , Li J , Wu C , Zhang H , Chen W , Diana J , Sun J , Chen YQ , |
|
|
Dietary Clostridium butyricum Induces a Phased Shift in Fecal Microbiota Structure and Increases the Acetic Acid-Producing Bacteria in a Weaned Piglet Model. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 66 Issue 20 Pages: 5157-5166 Pub: 2018 May 23 Epub: 2018 Apr 30 Authors Zhang J , Chen X , Liu P , Zhao J , Sun J , Guan W , Johnston LJ , Levesque CL , Fan P , He T , Zhang G , Ma X , |
|
|
Dietary Clostridium butyricum Induces a Phased Shift in Fecal Microbiota Structure and Increases the Acetic Acid-Producing Bacteria in a Weaned Piglet Model. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 66 Issue 20 Pages: 5157-5166 Pub: 2018 May 23 Epub: 2018 Apr 30 Authors Zhang J , Chen X , Liu P , Zhao J , Sun J , Guan W , Johnston LJ , Levesque CL , Fan P , He T , Zhang G , Ma X , |
|
|
The Anti-Inflammatory Effect and Mucosal Barrier Protection of Clostridium butyricum RH2 in Ceftriaxone-Induced Intestinal Dysbacteriosis. ✅
Go to Publication ✅
Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 11 Issue Pages: 647048 Pub: 2021 Epub: 2021 Mar 25 Authors Li Y , Liu M , Liu H , Sui X , Liu Y , Wei X , Liu C , Cheng Y , Ye W , Gao B , Wang X , Lu Q , Cheng H , Zhang L , Yuan J , Li M , |
|
|
The Anti-Inflammatory Effect and Mucosal Barrier Protection of Clostridium butyricum RH2 in Ceftriaxone-Induced Intestinal Dysbacteriosis. ✅
Go to Publication ✅
Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 11 Issue Pages: 647048 Pub: 2021 Epub: 2021 Mar 25 Authors Li Y , Liu M , Liu H , Sui X , Liu Y , Wei X , Liu C , Cheng Y , Ye W , Gao B , Wang X , Lu Q , Cheng H , Zhang L , Yuan J , Li M , |
|
|
The impact of Clostridium butyricum MIYAIRI 588 on the murine gut microbiome and colonic tissue. ✅
Go to Publication ✅
Anaerobe (Anaerobe ) Vol: 54 Issue Pages: 8-18 Pub: 2018 Dec Epub: 2018 Aug 1 Authors Hagihara M , Yamashita R , Matsumoto A , Mori T , Kuroki Y , Kudo H , Oka K , Takahashi M , Nonogaki T , Yamagishi Y , Mikamo H , |
|
|
Miya Improves Osteoarthritis Characteristics via the Gut-Muscle-Joint Axis According to Multi-Omics Analyses. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue Pages: 816891 Pub: 2022 Epub: 2022 May 20 Authors Xu T , Yang D , Liu K , Gao Q , Liu Z , Li G , |
|
|
Miya Improves Osteoarthritis Characteristics via the Gut-Muscle-Joint Axis According to Multi-Omics Analyses. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue Pages: 816891 Pub: 2022 Epub: 2022 May 20 Authors Xu T , Yang D , Liu K , Gao Q , Liu Z , Li G , |
|
|
Uncovering the mechanism of Clostridium butyricum CBX 2021 to improve pig health based on in vivo and in vitro studies. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1394332 Pub: 2024 Epub: 2024 Jun 14 Authors Liu X , Qiu X , Yang Y , Wang J , Wang Q , Liu J , Huang J , Yang F , Liu Z , Qi R , |
|
|
Uncovering the mechanism of Clostridium butyricum CBX 2021 to improve pig health based on in vivo and in vitro studies. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1394332 Pub: 2024 Epub: 2024 Jun 14 Authors Liu X , Qiu X , Yang Y , Wang J , Wang Q , Liu J , Huang J , Yang F , Liu Z , Qi R , |
|
|
Uncovering the mechanism of Clostridium butyricum CBX 2021 to improve pig health based on in vivo and in vitro studies. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1394332 Pub: 2024 Epub: 2024 Jun 14 Authors Liu X , Qiu X , Yang Y , Wang J , Wang Q , Liu J , Huang J , Yang F , Liu Z , Qi R , |
|
|
Uncovering the mechanism of Clostridium butyricum CBX 2021 to improve pig health based on in vivo and in vitro studies. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1394332 Pub: 2024 Epub: 2024 Jun 14 Authors Liu X , Qiu X , Yang Y , Wang J , Wang Q , Liu J , Huang J , Yang F , Liu Z , Qi R , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
